Tirzah Braz Petta

Prof. Tirzah Braz Petta

University of Southern California
+1
orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2011 in Molecular Cell
Verified
Journal Article
Closed access
AZAnastasia Zlatanou
Anastasia Zlatanou
EDEmmanuelle Despras
Emmanuelle Despras
TPTirzah Braz Petta
Tirzah Braz Petta
IBImenne Boubakour-Azzouz
Imenne Boubakour-Azzouz
CPCaroline Pouvelle
Caroline Pouvelle
PKPatricia L. Kannouche
Patricia L. Kannouche

16 October 2008 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
TPTirzah Braz Petta
Tirzah Braz Petta
SNSatoshi Nakajima
Satoshi Nakajima
AZAnastasia Zlatanou
Anastasia Zlatanou
EDEmmanuelle Despras
Emmanuelle Despras
SCSophie Couve‐Privat
Sophie Couve‐Privat
PKPatricia Kannouche
Patricia Kannouche
Human DNA polymerase iota (polι) is a unique member of the Y‐family of specialised polymerases that displays a 5′deoxyribose phosphate (dRP) lyase activity. Although polι is well conserved in higher eukaryotes, its role in mammalian cells remains unclear. To investigate the biological importance of polι in human cells, we generated fibroblasts stably downregulating polι (MRC5‐polιKD) and examined their response to several types of DNA‐damaging agents. We show that cell lines downregulating polι exhibit hypersensitivity to DNA damage induced by hydrogen peroxide (H2O2) or menadione but not to ethylmethane sulphonate (EMS), UVC or UVA. Interestingly, extracts from cells downregulating polι show reduced base excision repair (BER) activity. In addition, polι binds to chromatin after treatment of cells with H2O2 and interacts with the BER factor XRCC1. Finally, green fluorescent protein‐tagged polι accumulates at the sites of oxidative DNA damage in living cells. This recruitment is partially mediated by its dRP lyase domain and ubiquitin‐binding domains. These data reveal a novel role of human polι in protecting cells from oxidative damage.

15 June 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
EPEdenir Palmero
Edenir Palmero
DCDirce Maria Carraro
Dirce Maria Carraro
BABarbara Alemar
Barbara Alemar
MMMiguel Angelo Martins Moreira
Miguel Angelo Martins Moreira
ÂRÂndrea Ribeiro-Dos-Santos
Ândrea Ribeiro-Dos-Santos
PAPatricia Ashton-Prolla
Patricia Ashton-Prolla
The detection of germline mutations in BRCA1 and BRCA2 is essential to the formulation of clinical management strategies, and in Brazil, there is limited access to these services, mainly due to the costs/availability of genetic testing. Aiming at the identification of recurrent mutations that could be included in a low-cost mutation panel, used as a first screening approach, we compiled the testing reports of 649 probands with pathogenic/likely pathogenic variants referred to 28 public and private health care centers distributed across 11 Brazilian States. Overall, 126 and 103 distinct mutations were identified in BRCA1 and BRCA2, respectively. Twenty-six novel variants were reported from both genes, and BRCA2 showed higher mutational heterogeneity. Some recurrent mutations were reported exclusively in certain geographic regions, suggesting a founder effect. Our findings confirm that there is significant molecular heterogeneity in these genes among Brazilian carriers, while also suggesting that this heterogeneity precludes the use of screening protocols that include recurrent mutation testing only. This is the first study to show that profiles of recurrent mutations may be unique to different Brazilian regions. These data should be explored in larger regional cohorts to determine if screening with a panel of recurrent mutations would be effective.

1 January 2019 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
DPDaniele Maria Lopes Pinheiro
Daniele Maria Lopes Pinheiro
AOAna Helena Sales de Oliveira
Ana Helena Sales de Oliveira
LCLeonam Gomes Coutinho
Leonam Gomes Coutinho
FFFabrícia Lima Fontes-Dantas
Fabrícia Lima Fontes-Dantas
RORayssa Karla de Medeiros Oliveira
Rayssa Karla de Medeiros Oliveira
ALAgnez-Lima Fassarella Lucymara
Agnez-Lima Fassarella Lucymara

1 January 2015 in Mutation Research - Reviews in Mutation Research
Verified
Journal Article
Closed access
FFFabrícia Lima Fontes-Dantas
Fabrícia Lima Fontes-Dantas
DPDaniele Maria Lopes Pinheiro
Daniele Maria Lopes Pinheiro
ASAquiles Sales Craveiro Sarmento
Aquiles Sales Craveiro Sarmento
RORayssa Oliveira
Rayssa Oliveira
TPTirzah Braz Petta
Tirzah Braz Petta
ALAgnez-Lima Fassarella Lucymara
Agnez-Lima Fassarella Lucymara

29 August 2018 in Breast Cancer Research and Treatment
Verified
Journal Article
Closed access
PDF file
ATAna Rafaela de Souza Timoteo
Ana Rafaela de Souza Timoteo
AGAna Élida Menezes Magalhães Gonçalves
Ana Élida Menezes Magalhães Gonçalves
LSLucas Amadeus Porpino Sales
Lucas Amadeus Porpino Sales
BABetina Menezes Albuquerque
Betina Menezes Albuquerque
JSJorge Estefano Santana de Souza
Jorge Estefano Santana de Souza
TPTirzah Braz Petta
Tirzah Braz Petta